Cisplatin in renal transplant recipients: not an absolute contraindication

MOspace/Manakin Repository

Breadcrumbs Navigation

Cisplatin in renal transplant recipients: not an absolute contraindication

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/16073

[+] show full item record


Title: Cisplatin in renal transplant recipients: not an absolute contraindication
Author: LaVoy, Rachel E.; Hu, Peter T.; Ramasubbaiah, Rashmi
Keywords: kidney transplant
immunosuppression
squamous cell cancer
first line therapy
Date: 2012-11-15
Abstract: The chemotherapeutic agent cisplatin is usually contraindicated in renal transplant recipients due to its well-known side effect of nephrotoxicity, but is an important (and sometimes irreplaceable) drug in the management of cancer. We report a case of cisplatin usage concurrently with radiation (CRT) in unresectable head and neck cancer, along with a review of the literature.
URI: http://hdl.handle.net/10355/16073

This item appears in the following Collection(s)

[+] show full item record